[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Centre Hospitalier de Saint-Denis\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":416},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,17,0,[8,46,70,93,117,142,162,187,206,229,247,271,290,310,336,356,383],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100645117","community-acquired-pneumonia-due-to-chlamydia-pneumoniae-100645117",false,"NCT07679789","Community-acquired Pneumonia Due to Chlamydia Pneumoniae","Prevalence and Phenotyping of Chlamydia Pneumoniae Infections Among Pnuemonias Tested With Simplex and Multiplex PCR","CHLAMPAC","Inclusion Criteria:\n\n* Positive simplex or multiplex PCR for Chlamydia pneumoniae on an upper or lower respiratory tract specimen between January 2015 and December 2025.\n* Availability of clinical data allowing confirmation of pneumonia diagnosis.\n\nExclusion Criteria:\n\n* Patient opposition to the use of medical data for research purposes.\n* Absence of pneumonia diagnosis.\n* Insufficient clinical data for analysis.","ALL",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","This international retrospective Franco-Swiss study focuses on community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae.\n\nThe working hypothesis is that the prevalence of C. pneumoniae pneumonia is overestimated by the medical community.\n\nThe primary objective is to determine the true prevalence of C. pneumoniae infections among patients with pneumonia who underwent simplex or multiplex PCR testing.\n\nSecondary objectives include;\n\n1. Outpatient management\n2. Hospitalization in a medical ward\n3. Admission to the intensive care unit\n4. In-hospital mortality\n5. Radiological presentation of patients with community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae\n6. Prevalence of viral or bacterial co-infections associated with C. pneumoniae CAP",[24],"Community-Acquired Pneumonia",[26,27,28,29,30,31,32],"Chlamydia pneumoniae","Community-acquired pneumonia","Prevalence","PCR","Co-infection","Respiratory infection","Atypical pneumonia","NOT_YET_RECRUITING","2026-06-30",{"date":36,"type":37},"2026-07-01","ACTUAL",{"date":39,"type":20},"2026-06",{"date":41,"type":20},"2027-06",{"name":43,"class":44},"Centre Hospitalier de Saint-Denis","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":45},"100608850","geographic-analysis-of-cancer-patients-residences-at-delafontaine-hospital-100608850","NCT07206914","Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital","Inclusion Criteria:\n\n\\- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.\n\nExclusion Criteria:\n\n\\- Patients whose cancer treatment in the oncology department was completed before 2020.",{"count":53,"type":20},300,"This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.",[56,57,58,59,60,61],"Neoplasms","Oncology Service","Health Services Accessibility","Health Inequalities","Residence Characteristics","Transportation of Patients","2025-09-26",{"date":64,"type":37},"2025-10-03",{"date":66,"type":20},"2025-10-15",{"date":68,"type":20},"2026-04-15",{"name":43,"class":44},{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":77,"targetDuration":79,"studyType":21,"phases":4,"briefSummary":80,"conditions":81,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":90,"leadSponsor":92,"locationsCount":45},"100608674","medical-anthropology-and-migrants-in-precarious-situations-cared-for-in-intensive-and-post-intensive-care-units-100608674","NCT07204626","Medical Anthropology and Migrants in Precarious Situations, Cared for in Intensive and Post-intensive Care Units","Inclusion Criteria:\n\nFor patients:\n\nMale and female migrants (born outside of France and its territories, regardless of date of arrival, length of residence, or acquired nationality)\n\nAged 18 years or older\n\nLiving in or transiting through France\n\nWith or without residence permits or legal documentation\n\nHospitalized in ICUs and receiving care in post-ICU rehabilitation units (SRPR)\n\nProviding consent to participate in the study\n\nHaving good proficiency in French, Spanish, or Italian, or, if not, benefiting from professional interpretation (ISM) or cultural mediation ensuring effective communication\n\nHaving a psychological and neurological state compatible with providing informed consent and taking part in an interview\n\nFor healthcare professionals and associative actors:\n\nBeing a healthcare, social work, or associative professional\n\nInvolved in the medical, psycho-social, and\u002For legal support and care of migrant patients admitted to ICUs and SRPR\n\nProviding consent to participate in the study\n\nExclusion Criteria:\n\nFor patients:\n\nBeing born in France\n\nBeing a minor (\\\u003C18 years old)\n\nBeing under guardianship or curatorship\n\nHaving a neurological state incompatible with providing informed consent and taking part in an interview\n\nFor healthcare professionals and associative actors:\n\nNot being involved in the care of migrant patients admitted to ICUs and SRPR","18 Years",{"count":78,"type":20},100,"8 Months","Analyze the experience (perception, interpretation and incorporation - embodiment) that migrant people with low socio-economic status\u002Fprecarity have of their own health conditions for which they have come to be hospitalized in the Intensive Care Unit (ICU) and Post-Resuscitation Rehabilitation Care (PRRC).",[82,83,84,85],"Anthropology","Immigrant","Intensive Care (ICU)","Precariousness","2025-09-24",{"date":88,"type":37},"2025-10-02",{"date":66,"type":20},{"date":91,"type":20},"2026-07-15",{"name":43,"class":44},{"id":94,"slug":95,"hasResults":11,"nctId":96,"briefTitle":97,"officialTitle":97,"acronym":4,"eligibilityCriteria":98,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":99,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":101,"conditions":102,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":45},"100607785","clinical-and-biological-signs-of-dapagliflozin-overdose-in-icu-patients-with-metformin-poisoning-100607785","NCT07193069","Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Admission to an intensive care unit (ICU) due to acute drug poisoning\n* Documented exposure to either:\n* Metformin alone\n* Metformin in combination with dapagliflozin\n\nExclusion Criteria:\n\n* Patients under 18 years of age\n* No exposure to metformin\n* Exposure to dapagliflozin without metformin",{"count":100,"type":20},50,"This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.",[103,104,105,106,107,108],"Drug Overdose","Metformin","Dapagliflozin","Lactic Acidosis","Diabetic Ketoacidosis","Intensive Care Units","RECRUITING",{"date":111,"type":37},"2025-09-25",{"date":113,"type":37},"2025-04-11",{"date":115,"type":20},"2026-04-11",{"name":43,"class":44},{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":121,"acronym":4,"eligibilityCriteria":122,"healthyVolunteers":11,"sex":123,"minAge":76,"maxAge":4,"enrollmentInfo":124,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":126,"conditions":127,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":139,"leadSponsor":141,"locationsCount":45},"100608395","prevalence-of-carriage-of-extended-spectrum-beta-lactamase-esbl-producing-enterobacteria-in-preterm-premature-rupture-of-membranes--a-french-multicenter-cohort-study-100608395","NCT07200999","Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture of Membranes : A French Multicenter Cohort Study","Inclusion Criteria :\n\n* Pregnant women aged over 18 years\n* Diagnosed with premature rupture of membranes before term (between 23 weeks + 0 days and 36 weeks + 6 days of gestation)\n* Managed in one of the participating maternity hospitals\n\nExclusion Criteria :\n\n* No available microbiological sample\n* Minors or women under legal guardianship (curatorship, tutelage, or judicial protection)\n* Women who refuse the use of their clinical data for research purposes at admission or within one month after receiving the information document","FEMALE",{"count":125,"type":20},250,"This study looks at how common certain antibiotic-resistant bacteria (called extended-spectrum beta-lactamase-producing Enterobacteriaceae, or E-BLSE) are in pregnant women who experience premature breaking of their water before full term. The goal is to understand how often these bacteria are found, how long they stay, and what factors increase the risk of carrying them. This information will help doctors choose the best antibiotics to protect both the mother and baby from infections during and after pregnancy. The study follows women from the time of their membrane rupture until delivery, collecting samples to track the bacteria over time.",[128,129,130,131,132,133,134],"Premature Rupture of Membranes","Enterobacteriaceae","Beta-Lactams","Drug Resistance, Bacterial","Antibiotic Prophylaxis","Pregnancy","Intrauterine Infection","2025-09-23",{"date":137,"type":37},"2025-10-01",{"date":137,"type":20},{"date":140,"type":20},"2026-12-15",{"name":43,"class":44},{"id":143,"slug":144,"hasResults":11,"nctId":145,"briefTitle":146,"officialTitle":146,"acronym":4,"eligibilityCriteria":147,"healthyVolunteers":11,"sex":123,"minAge":76,"maxAge":148,"enrollmentInfo":149,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":150,"conditions":151,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":45},"100606022","comparison-of-uterine-distension-in-hysterosonography-among-patients-monitored-for-infertility-100606022","NCT07170137","Comparison of Uterine Distension in Hysterosonography Among Patients Monitored for Infertility","Inclusion Criteria:\n\n* Patient age ≥ 18 and \\\u003C 43 years old\n* No contraindications to pregnancy\n* Patients consulting at the Saint Denis assisted reproductive technology (ART) department due to desire to become pregnant or infertility\n\nExclusion Criteria:\n\n* Contraindication to assisted reproductive technology treatment","43 Years",{"count":19,"type":20},"Comparison of differences in distension by volumetric analysis of the uterus before and after distension between groups of infertile and apparently fertile women.",[152,153],"Infertile Women Undergoing IVF or ICSI","Distension by Volumetric Analysis of the Uterus","2025-09-05",{"date":156,"type":37},"2025-09-12",{"date":158,"type":37},"2025-07-15",{"date":160,"type":20},"2025-11-15",{"name":43,"class":44},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":168,"targetDuration":4,"studyType":170,"phases":171,"briefSummary":173,"conditions":174,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":180,"lastUpdatePostDateStruct":181,"startDateStruct":183,"completionDateStruct":184,"leadSponsor":186,"locationsCount":4},"100597674","objective-evaluation-of-cough-effort-in-tracheotomized-patients-lost-study-100597674","NCT07061561","Objective Evaluation of Cough Effort in Tracheotomized Patients (LOST Study)","Inclusion Criteria:\n\n* Adult patients (18 years or older)\n* Hospitalized in post-intensive care rehabilitation unit (SRPR) or intensive care unit (ICU)\n* Tracheotomized during the weaning process\n* Medical prescription for physiotherapy assessment\n* Medical prescription for speech therapy assessment\n\nExclusion Criteria:\n\n* Patients who have undergone total laryngectomy\n* Patients with severe swallowing disorders\n* Patients with cognitive impairments incompatible with understanding instructions\n* Patients under medical decision to stop active treatments\n* Patients who refuse to participate or refuse to sign informed consent\n* Patients under guardianship or curatorship\n* Patients not affiliated with a social security scheme",{"count":169,"type":20},34,"INTERVENTIONAL",[172],"NA","This study aims to evaluate how well tracheotomized patients can cough before and after their tracheostomy tube is removed. Cough strength is measured using two different tools-Peak Flow and Lorio. Researchers want to find out if the cough measurement taken before removing the tube can help predict how effective the patient's cough will be afterward. The study will also explore factors that might influence cough strength and compare the usefulness of the two tools. Additionally, it will assess how patients feel about using these devices and the role of diaphragm ultrasound in predicting cough effectiveness.",[175,176,177,178,179],"Tracheostomy","Cough","Weaning","Respiratory Function Tests","Diaphragm","2025-07-02",{"date":182,"type":37},"2025-07-11",{"date":158,"type":20},{"date":185,"type":20},"2026-11-15",{"name":43,"class":44},{"id":188,"slug":189,"hasResults":11,"nctId":190,"briefTitle":191,"officialTitle":191,"acronym":4,"eligibilityCriteria":192,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":193,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":194,"conditions":195,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":200,"lastUpdatePostDateStruct":201,"startDateStruct":203,"completionDateStruct":204,"leadSponsor":205,"locationsCount":45},"100597314","monotherapy-vs-combination-therapy-for-bone-infections-caused-by-pseudomonas-aeruginosa-100597314","NCT07056881","Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa","Inclusion Criteria:\n\n* Adult patients (≥18 years old)\n* Diagnosis of osteitis or osteomyelitis due to Pseudomonas aeruginosa\n* Isolation of Pseudomonas aeruginosa from at least one deep, sterile sample (e.g., bone biopsy, joint aspiration)\n* Imaging findings consistent with osteomyelitis (MRI, CT scan, or X-ray)\n\nExclusion Criteria:\n\n* No isolation of Pseudomonas aeruginosa\n* No imaging evidence suggestive of osteomyelitis\n* Patients under 18 years of age",{"count":53,"type":20},"This study looks at how well one antibiotic (monotherapy) works compared to two antibiotics (combination therapy) in treating bone infections caused by Pseudomonas aeruginosa. It includes 300 adult patients who had this type of infection confirmed by lab tests and medical imaging. The goal is to find out if using just one antibiotic is as effective as using two, while also looking at side effects, the need for more surgery, antibiotic resistance, and overall antibiotic use.",[196,197,198,199],"Osteomyelitis","Pseudomonas Infections","Pseudomonas Aeruginosa","Bacterial Infections","2025-06-30",{"date":202,"type":37},"2025-07-09",{"date":113,"type":37},{"date":68,"type":20},{"name":43,"class":44},{"id":207,"slug":208,"hasResults":11,"nctId":209,"briefTitle":210,"officialTitle":210,"acronym":4,"eligibilityCriteria":211,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":212,"targetDuration":4,"studyType":170,"phases":214,"briefSummary":215,"conditions":216,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":221,"lastUpdatePostDateStruct":222,"startDateStruct":224,"completionDateStruct":226,"leadSponsor":228,"locationsCount":45},"100596949","non-invasive-blood-pressure-monitoring-in-icu-patients-using-the-dare-device-100596949","NCT07052123","Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device","Inclusion Criteria:\n\n* Adult patients (male or female), aged 18 years or older\n* Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days\n* Equipped with an arterial catheter for invasive blood pressure monitoring\n* Equipped with a urinary catheter for invasive core body temperature monitoring\n\nExclusion Criteria:\n\n* Patients under 18 years old (minors)\n* Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use\n* History of extensive skin pathology (e.g., Lyell syndrome)\n* Patients with therapeutic limitations\n* Patients with active implanted medical devices (e.g., pacemaker, defibrillator)\n* Pregnant or breastfeeding women\n* Patients not affiliated with the French social security system\n* Patients or their legal representatives refusing consent, or unable to understand information and give informed consent\n* Patients under legal guardianship, curatorship, or deprived of liberty",{"count":213,"type":20},2,[172],"This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.",[217,218,108,219,220],"Hemodynamics","Blood Pressure Monitoring","Critical Illness","Monitoring, Physiologic","2025-06-26",{"date":223,"type":37},"2025-07-04",{"date":225,"type":37},"2025-03-24",{"date":227,"type":20},"2028-03-24",{"name":43,"class":44},{"id":230,"slug":231,"hasResults":11,"nctId":232,"briefTitle":233,"officialTitle":233,"acronym":4,"eligibilityCriteria":234,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":235,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":236,"conditions":237,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":221,"lastUpdatePostDateStruct":241,"startDateStruct":242,"completionDateStruct":244,"leadSponsor":246,"locationsCount":45},"100596986","antibiotic-treatment-for-pneumonia-caused-by-stenotrophomonas-maltophilia-in-icu-patients-100596986","NCT07052604","Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients","Inclusion Criteria:\n\n* Adult patients (age ≥ 18 years)\n* Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023\n* Intubated and mechanically ventilated\n* Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia\n\nExclusion Criteria:\n\n* Patients under 18 years old\n* Patients who refuse the use of their data for research purposes",{"count":53,"type":20},"This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.",[238,239,108,240,131],"Pneumonia, Ventilator-Associated","Stenotrophomonas Maltophilia","Anti-Bacterial Agents",{"date":223,"type":37},{"date":243,"type":37},"2023-12-15",{"date":245,"type":20},"2025-09-15",{"name":43,"class":44},{"id":248,"slug":249,"hasResults":11,"nctId":250,"briefTitle":251,"officialTitle":251,"acronym":4,"eligibilityCriteria":252,"healthyVolunteers":11,"sex":123,"minAge":76,"maxAge":4,"enrollmentInfo":253,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":255,"conditions":256,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":264,"lastUpdatePostDateStruct":265,"startDateStruct":267,"completionDateStruct":269,"leadSponsor":270,"locationsCount":45},"100593790","sexual-health-of-sub-saharan-african-migrant-women-recently-diagnosed-with-hiv-in-le-de-france-missed-opportunities-for-prevention-100593790","NCT07011017","Sexual Health of Sub-Saharan African Migrant Women Recently Diagnosed With HIV in Île-de-France: Missed Opportunities for Prevention","Inclusion Criteria:\n\n* Sub-Saharan African migrant women recently diagnosed with HIV (from 2021 onward)\n* HIV diagnosis made on French territory\n* Aged 18 years or older\n\nExclusion Criteria:\n\n* Inability to inform the patient about the study due to a language barrier or other obstacle\n* HIV diagnosis made before 2021\n* HIV diagnosis made in the country of origin\n* Under 18 years of age",{"count":254,"type":20},45,"This study looks at the sexual health of women from Sub-Saharan Africa who recently found out they have HIV after arriving in Île-de-France. It aims to understand their risk factors and identify missed chances for HIV testing and prevention. The goal is to improve care and support for these women by learning more about their experiences and the challenges they face.",[257,258,259,260,58,261,262,263],"HIV Infections","Sexual Health","Migrants","Women's Health","Sub-Saharan Africa","Risk-Taking","Vulnerable Populations","2025-05-30",{"date":266,"type":37},"2025-06-08",{"date":268,"type":20},"2025-06-15",{"date":160,"type":20},{"name":43,"class":44},{"id":272,"slug":273,"hasResults":11,"nctId":274,"briefTitle":275,"officialTitle":275,"acronym":4,"eligibilityCriteria":276,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":277,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":279,"conditions":280,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":282,"lastUpdatePostDateStruct":283,"startDateStruct":285,"completionDateStruct":287,"leadSponsor":289,"locationsCount":45},"100590590","representation-of-diet-in-the-management-of-type-2-diabetes-in-migrant-patients-at-chsd-100590590","NCT06969391","Representation of Diet in the Management of Type 2 Diabetes in Migrant Patients at CHSD","Inclusion Criteria:\n\n* Type 2 diabetic for at least 3 months\n* Arrived in France less than 7 years ago\n* Adult patient (age 18)\n* Speaking French or English\n\nExclusion Criteria:\n\n* Minor patient (age \\\u003C 18 years)\n* Type 1 diabetes\n* Does not speak French or English\n* Patient who has expressed opposition to the use of his data, or his refusal to participate",{"count":278,"type":20},11,"This observational and monocentric study aims to explore how migrant patients with type 2 diabetes perceive and represent food in the context of their diabetes care. Conducted at the Centre Hospitalier de Saint-Denis, the study investigates the cultural, social, and personal factors that influence dietary habits and how these perceptions affect the management of their condition. The goal is to improve the understanding of patient behaviors and support more culturally adapted care strategies.",[281],"Diabetes Mellitus, Type 2","2025-05-12",{"date":284,"type":37},"2025-05-13",{"date":286,"type":37},"2024-09-01",{"date":288,"type":20},"2025-09-01",{"name":43,"class":44},{"id":291,"slug":292,"hasResults":11,"nctId":293,"briefTitle":294,"officialTitle":294,"acronym":4,"eligibilityCriteria":295,"healthyVolunteers":11,"sex":123,"minAge":76,"maxAge":4,"enrollmentInfo":296,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":298,"conditions":299,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":302,"lastUpdatePostDateStruct":303,"startDateStruct":305,"completionDateStruct":307,"leadSponsor":309,"locationsCount":4},"100586943","study-effects-of-the-precapp-system-on-precarious-and-vulnerable-pregnant-women-100586943","NCT06921954","Study Effects of the PRECAPP System on Precarious and Vulnerable Pregnant Women","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Follow-up in 2023 at Gonesse Hospital\n* Patient having started her PRECAPP follow-up in 2023, between the 2nd and 5th month of pregnancy and having been accompanied throughout her PRECAPP journey (before, during and after childbirth): Classic\" PRECAPP pathway\n* Patient with integration (in 2023) of the PRECAPP program late in pregnancy (up to 1 month before delivery): PRECAPP \"late\" pathway\n* Vulnerable and precarious patient not followed by PRECAPP but who should have been (maternity course completed in 2023): PRECAPP \"non-integration\" pathway\n\nExclusion Criteria:\n\n* Patient without vulnerability\u002Fpoverty\n* Patient not followed at the CHG in 2023",{"count":297,"type":20},30,"The themes of city-hospital coordination, patient pathways and the decompartmentalization of the city-hospital-medical-social and social sectors are becoming a major preoccupation for the healthcare sector, and a key factor in its dynamic transformation. A number of initiatives taken in this direction, either by the regulatory authorities (development of tools to promote coordination between healthcare professionals), by hospital establishments or by city professionals (notably CPTS), attest to a growing interest in the subject.\n\nThe École des Mines de Paris, whose highly collaborative research methods (research-intervention) are anchored in concrete support for transformation projects, and the University of Lille (LUMEN) are thus increasingly called upon to support players in these areas.\n\nIn this context, collaborative work with a Quebec research team (Ecole Nationale d'Administration Publique and Université de Sherbrooke) was launched in 2023 to compare forms of healthcare pathway management between two different healthcare systems, and their effects on vulnerable people (elderly, disabled, migrants, homeless, etc.). In France, the quantitative component is based on the use of PMSI databases, and aims to analyze the characteristics of \"abnormally long\" patient stays, in order to identify variables (relating either to patients or to care) likely to explain longer lengths of stay. The qualitative component is based on interviews with professionals and the reconstruction of patient pathways marked by breaks in care. The aim is to understand the very notion of breakdowns, the mechanisms by which they occur and the strategies put in place to avoid or deal with them.\n\nCollaboration with the PRECAPP research team\n\nAs part of the qualitative component of the research program, the French team met several times between February and summer 2024 with members of the PRECAPP program. The PRECAPP system's function (to support vulnerable pregnant women in the perinatal period) and its mission (to identify the risks of disruption to care as early as possible in pregnancy, and to coordinate care during pregnancy and in the postnatal period) are at the heart of the Franco-Quebec research.\n\nAn initial working meeting between the PRECAPP team and the researchers provided an opportunity to describe the system and to demonstrate that its operation and the specific support it provides make it possible to anticipate certain difficulties in the care of women (before, during and after birth) and to help avoid disruptions in care.\n\nThe PRECAPP system is therefore fully in line with a comprehensive approach to the perinatal care of precarious and vulnerable women. This care concerns intra-hospital care, but it also contributes to the decompartmentalization of city-hospital care.\n\nIt is with the aim of highlighting the contributions of the PRECAPP system to the quality of care provided, the limits to its action, and to assess the way in which it helps to avoid breakdowns, that a collaboration between researchers and practitioners has been set up and will enable this study to be carried out.",[300,301],"Pregnant Women","Vulnerable Patients","2025-04-09",{"date":304,"type":37},"2025-04-10",{"date":306,"type":20},"2025-05",{"date":308,"type":20},"2025-09",{"name":43,"class":44},{"id":311,"slug":312,"hasResults":11,"nctId":313,"briefTitle":314,"officialTitle":314,"acronym":315,"eligibilityCriteria":316,"healthyVolunteers":11,"sex":17,"minAge":317,"maxAge":4,"enrollmentInfo":318,"targetDuration":4,"studyType":170,"phases":319,"briefSummary":320,"conditions":321,"keywords":323,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":328,"lastUpdatePostDateStruct":329,"startDateStruct":331,"completionDateStruct":333,"leadSponsor":335,"locationsCount":45},"100572619","pilot-study-ahsp-as-a-biomarker-of-sickle-cell-disease-in-a-population-of-adults-and-children-100572619","NCT06735625","Pilot Study \"AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children\"","AHSPDREP","Inclusion Criteria:\n\nInclusion Criteria for Sickle Cell Patients\n\n1. Adults: \\> 15 years and 6 months\n2. Pediatrics: ≥ 3 years and ≤ 15 years and 6 months\n3. Known SS or Sβ0 phenotypes\n\nInclusion Criteria for Control Patients.\n\n1 -Adults: \\> 15 years and 6 months \u002FPediatrics: ≥ 3 years and ≤ 15 years and 6 months 2-Absence of Hemoglobinopathy 3-Follow-up for one of the following conditions (adults): Evaluation of hematological disease excluding hemoglobinopathy, evaluation of prolonged fever or inflammatory syndrome, initial or episodic evaluation of an auto-inflammatory disease or systemic disease, general health deterioration\n\n-Follow-up for one of the following conditions (pediatrics): Suspected precocious puberty, growth delay, or neurodevelopmental disorder\n\n4-Blood sample planned as part of medical care\n\nExclusion Criteria:\n\n1. Hemoglobin disorder other than sickle cell disease (Criteria for Sickle Cell Patients)\n2. Hemoglobinopathies other than sickle cell disease (Criteria for Control Patients)\n3. Transfusion less than 3 months ago\n4. Chronic active viral disease: hepatitis B, C, HIV\n5. Current infections or known inflammatory pathologies\n6. Known hyper or hypothyroidism or subject treated with levothyroxine\n7. Active tumor pathology or remission for less than 5 years\n8. Oral corticosteroid therapy in progress\n9. Participation in interventional biomedical research\n10. Opposition to participation in research by the patient if he is an adult, or by one of the two parents if the patient is a minor.\n11. Non-affiliation to a social security system","3 Years",{"count":78,"type":20},[172],"Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients",[322],"in Relation to Sickle Cell Disease",[324,325,326,327],"AHSP","Sickle Cell Disease","SS Phenotype","Sβ0 Phenotype","2025-03-28",{"date":330,"type":37},"2025-04-02",{"date":332,"type":37},"2025-03-06",{"date":334,"type":20},"2027-01-20",{"name":43,"class":44},{"id":337,"slug":338,"hasResults":11,"nctId":339,"briefTitle":340,"officialTitle":340,"acronym":341,"eligibilityCriteria":342,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":343,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":345,"conditions":346,"keywords":4,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":348,"lastUpdatePostDateStruct":349,"startDateStruct":351,"completionDateStruct":353,"leadSponsor":355,"locationsCount":213},"100581673","validation-of-the-short-form-of-the-lower-urinary-tract-symptoms-treatment-constraints-assessment-questionnaire-100581673","NCT06853366","Validation of the Short Form of the \"Lower Urinary Tract Symptoms Treatment Constraints Assessment\" Questionnaire","FC-LUTS-TCA","Inclusion Criteria:\n\n* Adult patients (age ≥ 18 years)\n* Patients with central or peripheral neurological pathology, followed and managed for vesico-sphincter disorders\n* Patients receiving urinary treatment for more than 3 months\n* No therapeutic modification between D0 and D14 of the questionnaire\n* French-speaking patients (able to read, write and understand French)\n\nExclusion Criteria:\n\n* Minor patients (age ≤ 17 years)\n* Patients who have stopped urinary treatment\n* Patients with major cognitive impairment\n* Patients who speak little or no French\n* Patients who refused to participate in research, or who objected to the use of their data for research purposes",{"count":344,"type":20},242,"For many years, the evaluation of treatments has been a central issue in patient care. The various domains assessed have gradually evolved over time, ranging from satisfaction, improvement and quality of life, to the more recent introduction of the Patient Reported Outcome Measure (PROM). These questionnaires or measurement scales (PROMs) focus assessment on the patient and his or her direct experience. Statistical validation of numerous assessment tools has made it possible to quantify objectively many areas of assessment that were initially linked to the patient's feelings, and therefore to their subjectivity. Thus, improvement, quality of life, patient expectations and goal attainment have been the preferred areas for the development of these PROMs.\n\nHowever, certain areas have been sidelined in the creation of these tools. For example, the constraint of care or the side effects or negative effects of care have not been studied through specific means of evaluation.\n\nIn response to this shortcoming, we have developed a questionnaire specifically designed for neuro-urological treatments in a neurological patient population.\n\nThe LUTS-TCA (Lower Urinary Tract Symptoms Treatment Constraints Assessment) was developed in French and statistically validated in 2019.\n\nThe aim of the study is to create a short form of the LUTS TCA in French, in a population of neurological patients.\n\nThis short form, which would be easier to use and interpret, would simplify its use in everyday practice. Indeed, a large majority of neuro-urology patients suffer from neurodegenerative or progressive pathologies, marked by significant and disabling physical and psychological fatigue symptoms. Long-form questionnaires, or the addition of multiple assessment questionnaires during a single visit to the department, make overall assessment more complex.\n\nIn addition, this short-form questionnaire is presented in a slightly different form to the long-form version, showing several domains of constraint (physical, social, psychological and care system). This classification should simplify the interpretation and understanding of care constraint, by and for patients.\n\nFor the patient, the validation study will take place in 2 phases:\n\n* A first phase at the time of the consultation (Day 0): response to the questionnaires making up the study, i.e. the short form of the LUTS TCA (appendix 2), then the validated form of the LUTS TCA (22 questions) and finally the PGI (two questions).\n* A second phase, at a distance from the consultation (Day 14 post-consultation): response to the short form of the LUTS TCA (questionnaire handed out at the consultation, accompanied by a stamped envelope for return).",[347],"Urologic Disorders","2025-02-25",{"date":350,"type":37},"2025-02-28",{"date":352,"type":37},"2025-02-20",{"date":354,"type":20},"2026-12-01",{"name":43,"class":44},{"id":357,"slug":358,"hasResults":11,"nctId":359,"briefTitle":360,"officialTitle":361,"acronym":362,"eligibilityCriteria":363,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":364,"targetDuration":4,"studyType":170,"phases":366,"briefSummary":367,"conditions":368,"keywords":371,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":375,"lastUpdatePostDateStruct":376,"startDateStruct":378,"completionDateStruct":380,"leadSponsor":382,"locationsCount":45},"100580298","evaluate-a-local-program-to-reduce-the-risky-use-of-screens-by-children-under-3-based-on-the-experience-of-parents-who-successfully-stopped-this-exposure-100580298","NCT06835478","Evaluate a Local Program to Reduce the Risky Use of Screens by Children Under 3, Based on the Experience of Parents Who Successfully Stopped This Exposure.","Evaluate a Local Program to Reduce the Risky Use of Screens by Children Under 3, Based on the Experience of Parents Who Successfully Stopped This Exposure (EPURE)","EPURE","Inclusion Criteria:\n\n* Live in Saint-Denis (France)\n* Parent(s) of child(ren) for whom the family has declared that they have succeeded in stopping or totally modifying their behaviour with screens before the child's 3rd birthday (standard form for all health record follow-up examinations).\n* Declaration confirmed by the negativation of the SCREEN result calculated a posteriori for two periods (before and after stopping), at least 3 months apart.\n* No objection to the use of data for research purposes.\n\nExclusion Criteria:\n\n* Non-French-speaking public\n* Severe neurological or sensory disorder in the child\n* Child in alternating custody with difficulty accessing screen exposure in the other custody arrangement.\n* Refusal to use data",{"count":365,"type":20},290,[172],"Early exposure to screens puts children at risk of later neurodevelopmental delay. This exposure is particularly prevalent among the underprivileged populations in our study area, and we don't yet know the motivations, factors and constraints that need to be put in place to remedy the situation.\n\nOur approach is a bottom-up study, based on the experience of parents who stopped their child's exposure to screens before age 3, to develop a program to reduce early exposure to screens. This will then be tested on a larger scale via a randomized trial",[369,370],"Exposure","Child Development",[372,373,374],"screens","screens exposure","child Development","2025-02-17",{"date":377,"type":37},"2025-02-19",{"date":379,"type":20},"2025-04-01",{"date":381,"type":20},"2027-02-01",{"name":43,"class":44},{"id":384,"slug":385,"hasResults":11,"nctId":386,"briefTitle":387,"officialTitle":387,"acronym":388,"eligibilityCriteria":389,"healthyVolunteers":11,"sex":123,"minAge":76,"maxAge":4,"enrollmentInfo":390,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":392,"conditions":393,"keywords":399,"overallStatus":109,"whyStopped":4,"lastUpdateSubmitDate":408,"lastUpdatePostDateStruct":409,"startDateStruct":411,"completionDateStruct":413,"leadSponsor":415,"locationsCount":45},"100565235","sexual-agency-of-women-who-have-suffered-from-incests-100565235","NCT06639542","Sexual Agency of Women Who Have Suffered from Incest(s)","ASFI","Inclusion Criteria:\n\n* Age \\> 18 years old\n* Women who have suffered from incest or rape\n* Speak and understand French\n\nExclusion Criteria:\n\n* Refusal to participate\n* Non french-speakers",{"count":391,"type":20},10,"Case study, qualitative and exploratory approach with prospective research. This study is aimed at voluntary patients referred by the women center.\n\n* The first meeting will be the presentation of a sexo-psychomotor questionnaire, specifically made for this study. Then, if the participant is willing, the enroll for a psychomotor follow-up of 6 sessions personalized with specific objectives defined for the patient,from the questionnaire.\n* These therapy sessions can be renewed in discussion with the woman if we feel they would benefit from further follow-up. The psychomotor sessions last around 45 minutes and take place once every 15 days or 3 weeks with a variety of therapeutical techniques. This interval between sessions allows time for integration of the aspects addressed during the proposals, while ensuring continuity in the follow-up. They are aimed at developing body and emotional awareness, to help patients get to know themselves better, and experience moments in full awareness\n* End-of-follow interview with taking the questionnaire a second time, to determine, with the woman, any benefits of the \"sex-psychomotor\" care. The women will be supported in completing the questionnaire again, as they were during the initial session.",[394,395,396,397,398],"Rape Sexual Assault","Incest","Assault","Violence Against Women","Therapy",[400,401,402,403,404,405,406,407],"rape","incest","violence","sexual assault","sexuality","agency","psychomotricity","psychomotor therapy","2024-10-10",{"date":410,"type":37},"2024-10-15",{"date":412,"type":20},"2024-10-14",{"date":414,"type":20},"2025-04-20",{"name":43,"class":44},""]